Kathryn Monroe

age ~40

from Windsor, CA

Get Report

Also known as:

Kathryn Elizabeth Rummel
Kathryn E Rummel
Kathryn L Rummel
Katherine L Rummel
Kathy L Rummel
Katie Rummel
Katie Rummell

Connected to:

Kathryn Monroe Phones & Addresses

Windsor, CA
Sebastopol, CA
Santa Rosa, CA
Petaluma, CA
Oakland, CA
San Francisco, CA
Aptos, CA
Santa Cruz, CA
Medford, OR
Santa Barbara, CA
Redwood City, CA

Medicine Doctors

Kathryn J. Monroe

view source

Specialties:

Cardiovascular Disease

Work:

Wilmington Health
1202 Medical Ctr Dr, Wilmington, NC 28401
(910)3413300 (phone), (910)7721372 (fax)

Languages:

English
Spanish

Description:

Ms. Monroe works in Wilmington, NC and specializes in Cardiovascular Disease. Ms. Monroe is affiliated with New Hanover Regional Medical Center and New Hanover Regional Medical Center Orthopedic Hospital.

Us Patents

Methods For Treating Dysregulated Lipid Metabolism
view source
US Patent:

20230132366, Apr 27, 2023
Filed:

Nov 26, 2019
Appl. No.:

17/296506
Inventors:

- South San Francisco CA, US
Gilbert DI PAOLO - South San Francisco CA, US
Kai Lin LIN - South San Francisco CA, US
Kathryn M. MONROE - South San Francisco CA, US
Alicia A. NUGENT - South San Francisco CA, US
Bettina VAN LENGERICH - South San Francisco CA, US
Assignee:

DENALI THERAPEUTICS INC. - South San Francisco CA
International Classification:

C07K 16/28
A61P 3/00
Abstract:

Certain embodiments described herein provide a method for treating dysregulated lipid metabolism and/or inflammation in a mammal in need thereof, comprising administering to the mammal an effective amount of an agonist anti-triggering receptor expressed on myeloid cells 2 (TREM2) antibody.

Fusion Proteins Comprising Progranulin
view source
US Patent:

20210284702, Sep 16, 2021
Filed:

Jun 18, 2019
Appl. No.:

17/253391
Inventors:

- South San Francisco CA, US
Todd P. Logan - South San Francisco CA, US
Kathryn M. Monroe - South San Francisco CA, US
Ankita Srivastava - South San Francisco CA, US
Bettina Van Lengerich - South San Francisco CA, US
Assignee:

Denali Therapeutics Inc. - South San Francisco CA
International Classification:

C07K 14/475
Abstract:

Provided herein are fusion proteins that comprise progranulin and an Fc polypeptide. Methods of using such proteins to treat progranulin-associated disorders (e.g., a neurodegenerative disease, such as frontotemporal dementia (FTD)) are also provided herein.

Anti-Trem2 Antibodies And Methods Of Use Thereof
view source
US Patent:

20210214438, Jul 15, 2021
Filed:

Jan 15, 2021
Appl. No.:

17/151006
Inventors:

- South San Francisco CA, US
Zhenyu Gu - South San Francisco CA, US
Mihalis S. Kariolis - South San Francisco CA, US
Cathal S. Mahon - South San Francisco CA, US
Kathryn M. Monroe - South San Francisco CA, US
Joshua I. Park - South San Francisco CA, US
Rachel Prorok - South San Francisco CA, US
Adam P. Silverman - South San Francisco CA, US
Bettina Van Lengerich - South San Francisco CA, US
Assignee:

Denali Therapeutics Inc. - South San Francisco CA
International Classification:

C07K 16/28
Abstract:

In one aspect, antibodies that specifically bind to a human triggering receptor expressed on myeloid cells 2 (TREM2) protein are provided. In some embodiments, the antibody decreases levels of soluble TREM2 (sTREM2). In some embodiments, the antibody enhances TREM2 activity.